AstraZeneca
AZN
#64
Rank
$219.57 B
Marketcap
$70.82
Share price
1.14%
Change (1 day)
-7.63%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): $2.50

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is $2.50. In 2024 the company made an earnings per share (EPS) of $2.27 an increase over its 2023 EPS that were of $1.92.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)$2.5010.35%
2024$2.2718.23%
2023$1.9281.13%
2022$1.06631.03%
2021$0.14-88.11%
2020$1.22136.89%
2019$0.51-39.41%
2018$0.85-28.27%
2017$1.18-14.37%
2016$1.3824.11%
2015$1.12127.55%
2014$0.49-51.96%
2013$1.02-58.95%
2012$2.48-32.2%
2011$3.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Bristol-Myers Squibb
BMY
$2.68 6.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$1.39-44.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$6.90 175.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$1.56-37.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
$2.85 13.66%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
$12.36 393.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$9.07 261.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$7.79 210.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$10.16 305.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$6.43 156.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland